- Depression and anxiety in the elderly
- Pharmacologic treatment of psychotic depression
- Interaction between medical burden and somatization in late-life depression
- Association between depressive disorders, cerebrovascular disease, and fear of falling in the elderly
Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial.
JAMA. 2019 08 20;322(7):622-631
J Gerontol A Biol Sci Med Sci. 2019 Aug 20;:
N Engl J Med. 2019 07 18;381(3):243-251
Age, race/ethnicity, and comorbidities predict statin adherence after ischemic stroke or myocardial infarction.
Eur J Prev Cardiol. 2019 Jul 11;:2047487319861219
Management of Late-Life Depression in the Context of Cognitive Impairment: a Review of the Recent Literature.
Curr Psychiatry Rep. 2019 Jul 05;21(8):74
Brain Amyloid PET Tracer Delivery is Related to White Matter Integrity in Patients with Mild Cognitive Impairment.
J Neuroimaging. 2019 Jul 03;:
J Affect Disord. 2019 May 28;256:373-379
Assessing evidence quality in research reporting neurocognitive outcomes following paediatric temporal lobe surgery for epilepsy.
Epilepsy Res. 2019 Aug;154:116-123
Association between Sleep Disturbances and Medial Temporal Lobe Volume in Older Adults with Mild Cognitive Impairment Free of Lifetime History of Depression.
J Alzheimers Dis. 2019;69(2):413-421
Int Psychogeriatr. 2019 Apr;31(4):443-446
Senior Scientist, Toronto General Hospital Research Institute (TGHRI)
Affiliate Scientist, KITE (TRI)
Professor, Department of Psychiatry, University of Toronto